Parkinson’s disease is a chronic disease. During the first few years symptoms may disappear or be relieved by L-dopa in tablet form. However, as the disease progresses, achieving satisfactory treatment by tablets may be complicated and difficult to control the symptoms. The irregular emptying of the stomach through its orifice makes the medicine absorption in the bowel uneven. To eliminate this factor, medication may be administered through a tube directly to the small intestine, where L-dopa is absorbed. This ensures a more even and reliable supply of medication.
The following PDF file contains information about the Duodopa treatment system. Product specifications are followed by descriptions of testing the nasointestinal tube and permanent treatment using the PEG.
For a complete description on how to handle the pump, please use the operator manual.
(126 KB)
